However, the conclusions of meta-analyses of the association between CYP1A1 and CYP1B1 polymorphisms and PCa risk have been inconsistent [6,9,10,60], and so we endeavored to conduct a systematic meta-analysis to precisely estimate this association, and provide a more comprehensive and reliable conclusion. The gene discussed is CYP1B1; the disease is posterior cortical atrophy.